Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (9) , 1085-1088
- https://doi.org/10.1016/j.amjcard.2004.12.064
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL CholesterolNew England Journal of Medicine, 2004
- Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Achievement of low-density lipoprotein cholesterol goals: new strategies to address new guidelinesCardiology Clinics, 2003
- Cholesteryl Ester Transfer ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in HumansCirculation, 2002
- Secretion of preβ HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cellsAtherosclerosis, 1999
- Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed RabbitsJournal of Biological Chemistry, 1998